J-Long Group announced the closing of its initial public offering of 1,400,000 ordinary shares at a public offering price of $5.00 per share and listed the aggregate gross proceeds from the offering at $7 million. J-Long shares began trading on the Nasdaq Global Market on Jan. 24 under the symbol "JL," and the company has granted the underwriter a 45-day option to purchase an additional 210,000 shares at the public offering price
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering.
Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.